This page shows the latest Vyriad news and features for those working in and with pharma, biotech and healthcare.
Voyager-V1 is no exception, although Vyriad is also investigating intravenous administration of the therapy in a phase I trial. ... We look forward to working with Vyriad to explore this novel combination for patients with solid tumours.”.
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...